HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Mancuso Selected Research

PF-06651600

10/2020Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica Mancuso Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2018
2Ischemic Stroke
09/2016 - 03/2016
1Herpes Simplex
10/2020
1Infections
10/2020
1Rheumatoid Arthritis
10/2020
1Skin Diseases (Skin Disease)
10/2020
1Hepatocellular Carcinoma (Hepatoma)
10/2020
1Stroke (Strokes)
03/2016

Drug/Important Bio-Agent (IBA)

2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2019
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2SAM-760IBA
07/2018 - 01/2018
23- (4- (2- hydroxyethyl)piperazin- 1- yl)- 7- (6- methoxypyridin- 3- yl)- 1- (2- propoxyethyl)pyrido(3,4- b)pyrazin- 2(1H)- oneIBA
09/2016 - 03/2016
1Methotrexate (Mexate)FDA LinkGeneric
10/2020
1Tec protein-tyrosine kinaseIBA
10/2020
1PF-06651600IBA
10/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2020
1Antiviral Agents (Antivirals)IBA
10/2020
1O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA
01/2020
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020
1Aspartic Acid ProteasesIBA
01/2019
1PF-06751979IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1imidazoleIBA
07/2018
1Donepezil (Aricept)FDA LinkGeneric
01/2018
1serotonin 6 receptorIBA
01/2018
1Pharmaceutical PreparationsIBA
09/2016
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
03/2016

Therapy/Procedure

2Therapeutics
10/2020 - 01/2020